Dolby Laboratories (NYSE:DLB) Issues Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its first quarter 2025 earnings guidance on Tuesday. The company provided EPS guidance of 0.960-1.110 for the period, compared to the consensus EPS estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Analyst Ratings Changes

Several research firms have recently issued reports on DLB. StockNews.com upgraded shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday. Barrington Research reissued an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 20th.

Dolby Laboratories Stock Down 0.6 %

Shares of NYSE:DLB traded down $0.42 during midday trading on Tuesday, reaching $70.93. 416,799 shares of the company traded hands, compared to its average volume of 396,175. The firm’s fifty day moving average price is $73.66 and its two-hundred day moving average price is $76.09. The firm has a market capitalization of $6.76 billion, a price-to-earnings ratio of 32.38 and a beta of 0.98. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06.

Dolby Laboratories announced that its Board of Directors has initiated a share repurchase program on Wednesday, August 7th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to purchase up to 5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Insider Activity

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total value of $2,113,309.44. Following the completion of the transaction, the chief executive officer now directly owns 83,721 shares of the company’s stock, valued at $6,205,400.52. This trade represents a 25.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 39.54% of the stock is owned by company insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.